SCHEMBL30724486

SCHEMBL30724486

NC(=O)c1cn(C(CO)c2cccc(Cl)c2)cn1

nearest known ligand 0.74

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADA P00813 12/20 0.74
ADRA1D P25100 1/20 0.41
PARP1 P09874 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7452471 0.85 ADA (1.00) ADA
SCHEMBL31069509 0.75 HSD17B10 (0.45) ADAADRA1DMAPK1
SCHEMBL9714567 0.72 ADA (0.66) ADA
SCHEMBL10414274 0.72 KDM2B (0.47) ADAPARP1MAPK1
SCHEMBL7457279 0.68 ADA (0.78) ADA
SCHEMBL7664339 0.67 ADA (0.69) ADA
SCHEMBL7668671 0.67 ADA (0.77) ADA
SCHEMBL7827340 0.66 ADA (0.61) ADA
Fr-221647 SCHEMBL7659103 0.66 ADA (1.00) ADA
Urea SCHEMBL27762549 0.66 CACNA2D1 (0.52) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107922387-B Heterocyclic inhibitors of ERK1 and ERK2 and their use in cancer treatment 阿沙纳生物科学公司 2024-11-22 CN disclosed
CN-113200961-B Heterocyclic inhibitors of ERK1 and ERK2 and their use in cancer treatment 阿沙纳生物科学公司 2023-12-22 CN disclosed